<DOC>
	<DOCNO>NCT01225614</DOCNO>
	<brief_summary>This multicenter randomize control open label study test efficacy tolerance early launching night non invasive ventilation patient myotonic dystrophy type 1 ( DM1 ) . The object project estimate effect early introduction non invasive ventilation arise complication ( non expect hospitalization , tracheostomy even death ) regard simple respiratory follow-up patient affect myotonic dystrophy .</brief_summary>
	<brief_title>Efficacy Tolerance Early Launching Nocturnal Non Invasive</brief_title>
	<detailed_description>DM1 frequent genetic myopathy adult . Actually curative treatment , symptomatic care essential . The respiratory impairment main cause morbid-mortality patient . The median survival patient affect DM1 respiratory failure 59 year . Mechanisms disease complex imply central direct impairment respiratory muscle . These patient present alveolar hypoventilation , notably night , correlate muscular weakness . These patient often present cognitive impairment complicate interpretation clinical symptom compliance treatment . International recommendation launch mechanical ventilation neuromuscular disease presence : 1 ) least clinical sign alveolar hypoventilation , one follow criterion 2 ) diurnal hypercapnia ( &gt; 45 mmHg ) , 3 ) restrictive syndrome ( vital capacity &lt; 50 % and\or maximal inspiratory pressure &lt; 60 cmH20 ) , 4 ) existence oxygen night-desaturation ( SaO2 &lt; 88 % ) 5 minute . However , Cochrane meta analyze underline absence randomise study estimate profit risk long term night-mechanical ventilation progressive myopathy DM1 . The validity criterion effect ventilation survival complication never estimate DM1 . On retrospective series , compliance inferior observance 20 % year incidence complication ( death resort tracheostomy ) 6 time important non observant patient . Objective ( ) clinical study To estimate efficiency tolerance long term night-non invasive mechanical ventilation patient affect DM1 . Main judgment criterion : Mortality non program hospitalization . Experimental plan : Multicenter , national , randomize , control , study 2 parallel group . The subject present theoretical indication follow consensual criterion ventilation randomize either start ventilation annual monitoring . Hypothesis : Early start non invasive ventilation allow reduction 20 % mortality number non-programmed hospitalization compare control group rate would 40 % .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<mesh_term>Muscle Weakness</mesh_term>
	<criteria>Man woman age â‰¥ 18 year Preliminary medical examination Enlightened write consent Genetically prove Steinert disease 1 . Presenting least one follow 3 criterion A hypercapnia : PaCO2 &gt; 45 mmHg A nightdesaturation : SaO2 &lt; 88 % consecutive 5 minute Apnea syndrome significant sleep : index apnea / hypopnea &gt; 30 / hour 2 . And presence least clinical sign : dyspnoea , orthopnea , headache , asthenia , diurnal sleepiness , sign suggestive disturbance sleep respiratory dysfunction Age inferior 18 Regime legal protection Pregnancy Absolute indication ventilation : clinical sign ( dyspnoea , orthopnea , headache , asthenia , diurnal sleepiness ) , AND PaCO2 &gt; 60 mmHg , AND nightdesaturation &lt; 88 % AND one CV &lt; 50 % theoretical PIMAX &lt; 60 cm H2O Acute respiratory failure Already ventilate patient Patient oxygen Not ( beneficiary regime Social Security legal successor )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Home ventilation</keyword>
	<keyword>Myotonic dystrophy type 1 ( DM1 )</keyword>
</DOC>